Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
5
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
US Stock MarketDetailed Quotes
Soleno Therapeutics(Delisted) (SLNO)
- 53.010
- 0.0000.00%
Close May 15 16:00 ET
2.76BMarket Cap27.47P/E (TTM)
0.000High0.000Low0Volume0.000Open53.010Prev Close0.00Turnover0.00%Turnover Ratio135.92P/E (Static)52.12MShares90.32052wk High5.57P/B2.73BFloat Cap29.43052wk Low--Dividend TTM51.45MShs Float742.500Historical High--Div Yield TTM0.00%Range %0.850Historical Low--Avg Price1Lot Size
Soleno Therapeutics(Delisted) (SLNO) News
News On Soleno Therapeutics Inc. (SLNO) Now Under NBIX
Cantor Fitzgerald Suspends Neutral Rating on Soleno Therapeutics
Soleno Therapeutics Completes Merger and Delists From Nasdaq
Neurocrine Biosciences Finalizes $2.9 Billion Acquisition of Soleno Therapeutics
Neurocrine Biosciences Completes Acquisition of Soleno Therapeutics
LifeSci Capital Reaffirms Their Buy Rating on Upstream Bio, Inc. (UPB)
10 Top Press Releases From April
Soleno Therapeutics | 10-Q: Q1 2026 Earnings Report
Press Release: Neurocrine Biosciences Reports First-Quarter 2026 Financial Results
Organon & Co Is the Best Performing Healthcare Stock in April
Soleno Therapeutics | 10-K/A: Annual report (Amendment)
Express News | EMA's Chmp: Application for Initial Marketing Authorisation Was Withdrawn for Viokat
Apellis Pharmaceuticals Is the Most Overbought Healthcare Stock as Q1 Earnings Roll on
Soleno Therapeutics Cut to Equal-Weight From Overweight by Wells Fargo
Wells Fargo Downgrades Soleno Therapeutics(SLNO.US) to Hold Rating, Cuts Target Price to $53
Soleno's VYKAT XR Real-World Study Adds Fuel to the Prader-Willi Investment Story
Key Deals This Week: Organon, UMG, Whitestone REIT, Gilead and More
LifeSci Capital Maintains Soleno Therapeutics(SLNO.US) With Hold Rating, Maintains Target Price $53
Analysts Offer Insights on Healthcare Companies: Enliven Therapeutics (ELVN), Viridian Therapeutics (VRDN) and Soleno Therapeutics (SLNO)
This Soleno Therapeutics Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
On June 3, Eastern Time, the U.S. House of Representatives passed a resolution limiting Trump's authority to use military force against Iran
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm